colloidal gold-bound tumor necrosis factor
Recombinant proteinexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2006 (NCT00356980)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
- Adrenocortical Carcinoma · Early Phase 1
- Breast Neoplasms · Early Phase 1
- Colorectal Neoplasms · Early Phase 1
- Gastrointestinal Neoplasms · Early Phase 1
- Kidney Neoplasms · Early Phase 1
- Liver Neoplasms · Early Phase 1
- Melanoma · Early Phase 1
- Neoplasms · Phase 1
- Ovarian Neoplasms · Early Phase 1
- Pancreatic Neoplasms · Early Phase 1
- Sarcoma · Early Phase 1
Mechanism of action
- TNF-alphaAGONIST
TNF agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- colloidal gold-bound tumor necrosis factor
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00436410 | Early Phase 1 (Phase 1) | Dec 1, 2006 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
| NCT00356980 | Phase 1 | May 1, 2006 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2006 |
| National Institutes of Health (NIH) | Government | 2 | 2 | 1 | 2006 |
2 organizations
Page 1 / 1